AIDS Drug Price Cuts Are Key To Coverage Expansion - Schondelmeyer
Executive Summary
AIDS drug manufacturers should trade price cuts for increased coverage by government agencies, University of Minnesota PRIME Institute Director Stephen Schondelmeyer, PhD, told the Presidential Advisory Council on HIV/AIDS Nov. 18.
You may also be interested in...
Bristol-Funded Africa HIV/AIDS Research Program Will Treat Subjects For Life
Patients enrolled in clinical trials supported by Bristol-Myers Squibb's "Secure the Future" international HIV/AIDS research and community outreach program will have access to treatment for life.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011